William Blair Reiterates “Market Perform” Rating for U.S. Physical Therapy (NYSE:USPH)

U.S. Physical Therapy (NYSE:USPH)‘s stock had its “market perform” rating restated by research analysts at William Blair in a research note issued to investors on Thursday,RTT News reports. William Blair also issued estimates for U.S. Physical Therapy’s Q1 2025 earnings at $0.56 EPS, Q1 2025 earnings at $0.56 EPS, Q2 2025 earnings at $0.79 EPS, Q2 2025 earnings at $0.79 EPS, Q4 2025 earnings at $0.78 EPS, Q4 2025 earnings at $0.78 EPS, FY2025 earnings at $2.96 EPS and FY2025 earnings at $2.96 EPS.

A number of other brokerages have also commented on USPH. JMP Securities initiated coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price objective for the company. JPMorgan Chase & Co. lifted their price target on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 3rd. Barrington Research restated an “outperform” rating and issued a $108.00 price objective on shares of U.S. Physical Therapy in a report on Thursday, November 21st. Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and raised their price objective for the company from $100.00 to $115.00 in a research note on Monday, December 16th. Finally, Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $111.50.

U.S. Physical Therapy Trading Down 1.6 %

Shares of NYSE USPH opened at $81.08 on Thursday. U.S. Physical Therapy has a 1-year low of $76.18 and a 1-year high of $113.63. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The company has a 50-day moving average of $88.41 and a two-hundred day moving average of $87.67. The company has a market cap of $1.22 billion, a PE ratio of 86.26, a P/E/G ratio of 3.54 and a beta of 1.48.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing the consensus estimate of $0.69 by ($0.04). The company had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. As a group, equities analysts expect that U.S. Physical Therapy will post 2.67 earnings per share for the current fiscal year.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of U.S. Physical Therapy stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $96.25, for a total transaction of $49,665.00. Following the transaction, the chief financial officer now directly owns 20,469 shares in the company, valued at approximately $1,970,141.25. The trade was a 2.46 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On U.S. Physical Therapy

Hedge funds have recently modified their holdings of the business. CBIZ Investment Advisory Services LLC grew its position in shares of U.S. Physical Therapy by 59.8% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock valued at $29,000 after purchasing an additional 122 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of U.S. Physical Therapy in the fourth quarter valued at approximately $39,000. Venturi Wealth Management LLC boosted its holdings in shares of U.S. Physical Therapy by 3,200.0% in the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock valued at $64,000 after buying an additional 704 shares during the period. KBC Group NV increased its position in shares of U.S. Physical Therapy by 68.6% during the third quarter. KBC Group NV now owns 774 shares of the company’s stock worth $66,000 after acquiring an additional 315 shares in the last quarter. Finally, Lazard Asset Management LLC acquired a new stake in shares of U.S. Physical Therapy during the fourth quarter worth $84,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.